| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2215/CJN.04071206 |
| P8608 | Fatcat ID | release_wnz7xf7zybgztl4nkgrkih7q3q |
| P698 | PubMed publication ID | 17699463 |
| P2093 | author name string | Robert H Mak | |
| Ihab M Wahba | |||
| P433 | issue | 3 | |
| P921 | main subject | obesity | Q12174 |
| metabolic syndrome | Q657193 | ||
| P304 | page(s) | 550-562 | |
| P577 | publication date | 2007-03-14 | |
| P1433 | published in | Clinical Journal of the American Society of Nephrology | Q15757929 |
| P1476 | title | Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease | |
| P478 | volume | 2 |
| Q27331760 | A blueberry-enriched diet improves renal function and reduces oxidative stress in metabolic syndrome animals: potential mechanism of TLR4-MAPK signaling pathway |
| Q64970867 | A novel resveratrol analog PA19 attenuates obesity‑induced cardiac and renal injury by inhibiting inflammation and inflammatory cell infiltration. |
| Q55456109 | A novel vibration-induced exercise paradigm improves fitness and lipid metabolism of Caenorhabditis elegans. |
| Q30978054 | A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes |
| Q63440925 | ACACβ gene (rs2268388) and AGTR1 gene (rs5186) polymorphism and the risk of nephropathy in Asian Indian patients with type 2 diabetes |
| Q35012428 | ACE inhibition is renoprotective among obese patients with proteinuria |
| Q35818630 | Abdominal Adipose Tissue was Associated with Glomerular Hyperfiltration among Non- Diabetic and Normotensive Adults with a Normal Body Mass Index |
| Q36179961 | Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model. |
| Q26798068 | Alteration of Fatty Acid Oxidation in Tubular Epithelial Cells: From Acute Kidney Injury to Renal Fibrogenesis |
| Q46929763 | Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity |
| Q34979668 | Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity |
| Q28730621 | Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3 |
| Q98290844 | Anti-obesity effect of a hop-derived prenylflavonoid isoxanthohumol in a high-fat diet-induced obese mouse model |
| Q36909985 | Antidiabetic and Antinephritic Activities of Aqueous Extract of Cordyceps militaris Fruit Body in Diet-Streptozotocin-Induced Diabetic Sprague Dawley Rats |
| Q41536906 | Association Between Body Mass Index Combined with Albumin: creatinine Ratio and All-cause Mortality in Chinese Population |
| Q85008903 | Association between prehypertension and chronic kidney disease in the Japanese general population |
| Q44451538 | Association of body mass index with glomerular filtration rate in Japanese: a cross-sectional study in work-site population. |
| Q28660741 | Association of metabolic syndrome with kidney function and histology in living kidney donors |
| Q50135660 | Association of physical capacity with heart rate variability based on a short-duration measurement of resting pulse rate in older adults with obesity |
| Q35117283 | Association of visceral adiposity with increased intrarenal artery resistive index in HIV-1-infected patients receiving highly active antiretroviral therapy |
| Q37521278 | Astragaloside IV Attenuates Podocyte Apoptosis Mediated by Endoplasmic Reticulum Stress through Upregulating Sarco/Endoplasmic Reticulum Ca2+-ATPase 2 Expression in Diabetic Nephropathy |
| Q35070137 | Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammation |
| Q47255994 | Bariatric Surgery can Reduce Albuminuria in Patients with Severe Obesity and Normal Kidney Function by Reducing Systemic Inflammation |
| Q37843766 | Bariatric surgery and renal function |
| Q51263117 | Body mass index and annual estimated GFR decline in Chinese adults with normal renal function. |
| Q87289944 | Body mass index and preclinical kidney disease in Indian adults aged 40 years and above without chronic kidney disease |
| Q44065003 | Body mass index trend in haemodialysis patients: the shift of nutritional disorders in two Italian regions |
| Q55212252 | Bowman Capsule Volume and Related Factors in Adults With Normal Renal Function. |
| Q36556374 | Caffeic Acid Phenethyl Ester Regulates PPAR's Levels in Stem Cells-Derived Adipocytes |
| Q58557762 | Can childhood obesity influence later chronic kidney disease? |
| Q86553719 | Chapter 3: Management of progression and complications of CKD |
| Q86553726 | Chapter 5: Referral to specialists and models of care |
| Q38171244 | Clinical biomarkers in metabolic syndrome |
| Q41843005 | Clinical epidemiology of reduced kidney function among elderly male fishing and agricultural population in Taipei, Taiwan |
| Q41420644 | Coenzyme Q10 Improves Lipid Metabolism and Ameliorates Obesity by Regulating CaMKII-Mediated PDE4 Inhibition |
| Q53793103 | Combined body mass index with high-sensitivity C-reactive protein as independent predictors for chronic kidney disease in a relatively healthy population in Taiwan. |
| Q90655360 | Comparison of high-fat style diet-induced dysregulation of baroreflex control of renal sympathetic nerve activity in intact and ovariectomized female rats: Renal sympathetic nerve activity in high-fat style diet fed intact and ovariectomized female |
| Q99709046 | Complement Properdin Regulates the Metabolo-Inflammatory Response to a High Fat Diet |
| Q47302626 | Compliance with a structured weight loss program is associated with reduced systolic blood pressure in obese patients with chronic kidney disease |
| Q37511029 | Consequences of morbid obesity on the kidney. Where are we going? |
| Q38320900 | Correlation of ultrasonographic measurement of intrarenal arterial resistance index with microalbuminuria in nonhypertensive, nondiabetic obese patients |
| Q36763648 | Correlation of visceral adiposity index with chronic kidney disease in the People's Republic of China: to rediscover the new clinical potential of an old indicator for visceral obesity |
| Q40142078 | Cyanidin-3-glucoside increases whole body energy metabolism by upregulating brown adipose tissue mitochondrial function |
| Q34270500 | DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat |
| Q90748230 | Defective Mitochondrial Fatty Acid Oxidation and Lipotoxicity in Kidney Diseases |
| Q35610072 | Diabetes mellitus and the risk of urolithiasis: a meta-analysis of observational studies |
| Q36951243 | Diabetes mellitus as a cause of end-stage renal disease in Europe: signs of improvement |
| Q41630778 | Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats |
| Q44896182 | Early improvement in albuminuria in non-diabetic patients after Roux-en-Y bariatric surgery |
| Q28547970 | Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial |
| Q40228971 | Effect of Different Obesity Phenotypes on Incidence of Chronic Kidney Disease in Tehranian Adults |
| Q39079610 | Effect of a High-Protein Energy-Restricted Diet Combined with Resistance Training on Metabolic Profile in Older Individuals with Metabolic Impairments |
| Q99569227 | Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials |
| Q33818281 | Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion |
| Q36152742 | Effects of Bariatric Surgery on Renal Function in Obese Patients: A Systematic Review and Meta Analysis |
| Q36047552 | Effects of metabolic syndrome on kidney transplantation outcomes: a systematic review and meta-analysis. |
| Q46879565 | Erythrocyte osmotic fragility and general health status of adolescent Sprague Dawley rats supplemented with Hibiscus sabdariffa aqueous calyx extracts as neonates followed by a high-fructose diet post-weaning. |
| Q37677727 | Estimating Negative Effect of Abdominal Obesity on Mildly Decreased Kidney Function Using a Novel Index of Body-Fat Distribution. |
| Q46839837 | Evaluation of microalbuminuria in obese children and its relation to metabolic syndrome |
| Q38209300 | Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease |
| Q64093630 | Fluvastatin Sodium Ameliorates Obesity through Brown Fat Activation |
| Q64229549 | Gender- and Age-Specific Associations between Visceral Obesity and Renal Function Impairment |
| Q34043086 | Ghrelin in chronic kidney disease |
| Q37575609 | Ginsenoside Rg1 suppresses early stage of adipocyte development via activation of C/EBP homologous protein-10 in 3T3-L1 and attenuates fat accumulation in high fat diet-induced obese zebrafish |
| Q47106733 | Glomerulopathy Associated With Moderate Obesity. |
| Q45809817 | Grape seed and skin extract alleviates high-fat diet-induced renal lipotoxicity and prevents copper depletion in rat. |
| Q90178919 | High levels of fasting glucose and glycosylated hemoglobin values are associated with hyperfiltration in a Spanish prediabetes cohort. The PREDAPS Study |
| Q37066329 | High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation |
| Q37734623 | Higher glomerular filtration rate is related to insulin resistance but not to obesity in a predominantly obese non-diabetic cohort. |
| Q37709360 | Hypertension and obesity after pediatric kidney transplantation: management based on pathophysiology: a mini review |
| Q35129384 | Hypertriglyceridemic waist phenotype and chronic kidney disease in a Chinese population aged 40 years and older |
| Q36946421 | Impact of Type 2 Diabetes on Impaired Kidney Function in Sub-Saharan African Populations |
| Q39631387 | Impact of metabolic syndrome on the incidence of chronic kidney disease: a Chinese cohort study |
| Q90421219 | Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity |
| Q35567862 | Impact of obesity on kidney function and blood pressure in children |
| Q37563980 | Impact of treating the metabolic syndrome on chronic kidney disease |
| Q57718011 | Implications for kidney disease in obese children and adolescents |
| Q40468739 | Improvement in liver histology due to lifestyle modification is independently associated with improved kidney function in patients with non-alcoholic steatohepatitis. |
| Q35543224 | Increased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferation |
| Q35904102 | Inflammation and oxidative stress in obesity-related glomerulopathy |
| Q40188954 | Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice |
| Q36967815 | Insulin and its role in chronic kidney disease |
| Q34018585 | Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review |
| Q37148712 | Intrarenal renin-angiotensin system mediates fatty acid-induced ER stress in the kidney |
| Q33597287 | Inverse associations between androgens and renal function: the Young Men Cardiovascular Association (YMCA) study |
| Q43187650 | Involvement of visceral fat in the pathogenesis of albuminuria in patients with type 2 diabetes with early stage of nephropathy |
| Q90050056 | Irisin Exerts Inhibitory Effect on Adipogenesis Through Regulation of Wnt Signaling |
| Q38059630 | Is obesity a risk factor for chronic kidney disease in children? |
| Q37068381 | Kidney function in obese adolescents with or without metabolic syndrome in a nationally-representative sample of pediatric population: First report from the Middle East and North Africa: The CASPIAN-III Study: A Case-Control Study |
| Q40443314 | Kidney outcomes three years after bariatric surgery in severely obese adolescents. |
| Q35695693 | Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney disease |
| Q92671897 | Left ventricular mass index and subendocardial myocardial function in children with chronic kidney disease, a transmural strain and three-dimensional echocardiographic study |
| Q37182203 | Lifestyle-induced metabolic inflexibility and accelerated ageing syndrome: insulin resistance, friend or foe? |
| Q37980001 | Lipid nephrotoxicity: new concept for an old disease |
| Q38289344 | Lipidomic analysis reveals significant lipogenesis and accumulation of lipotoxic components in ob/ob mouse organs |
| Q55223580 | Long-term risk for end-stage kidney disease and death in a large population-based cohort. |
| Q50967646 | Longitudinal relationships of metabolic syndrome and obesity with kidney function: Healthy Twin Study. |
| Q33812172 | MRI-determined fat content of human liver, pancreas and kidney |
| Q38751663 | Maladaptive Cardiac Autonomic Control during a Stress Reactivity Assessment Among Primary Care Patients with Metabolic Syndrome. |
| Q27027141 | Management of obesity-induced kidney disease: a critical review of the literature |
| Q36654960 | Medaka fish, Oryzias latipes, as a model for human obesity-related glomerulopathy |
| Q56394611 | Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study |
| Q84960392 | Metabolic Syndrome and Chronic Kidney Disease |
| Q38137667 | Metabolic syndrome and associated chronic kidney diseases: nutritional interventions |
| Q34453266 | Metabolic syndrome and chronic kidney disease: Current status and future directions |
| Q84573076 | Metabolic syndrome and urinary stone composition: what factors matter most? |
| Q42757693 | Metabolic syndrome and urologic diseases |
| Q40954876 | Metabolic syndrome does not always play a critical role in decreased GFR. |
| Q36910935 | Metabolic syndrome, ESRD, and death in CKD. |
| Q87935711 | Metabolically Healthy Obesity and Risk of Kidney Function Decline |
| Q33907267 | Metabolically healthy obesity: a friend or foe? |
| Q54264269 | Mild alcohol intake exacerbates metabolic syndrome in rodents: a putative role of GSK-3β. |
| Q35126070 | Multiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress |
| Q37257080 | Neck circumference predicts renal function decline in overweight women: A community-based prospective cohort study. |
| Q37161462 | New aspects of the relationship among hypertension, obesity, and the kidneys |
| Q46593121 | Nicotine Enhances High-Fat Diet-Induced Oxidative Stress in the Kidney |
| Q35282636 | Nicotinic acetylcholine receptor α1 promotes calpain-1 activation and macrophage inflammation in hypercholesterolemic nephropathy |
| Q54420633 | Nlrp3 is a key modulator of diet-induced nephropathy and renal cholesterol accumulation. |
| Q83341713 | Obesity and preterm birth: additive risks in the progression of kidney disease in children |
| Q35958492 | Obesity and renovascular disease |
| Q46941041 | Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study |
| Q37335044 | Obesity, inflammation, and kidney disease. |
| Q36275424 | Obesity-induced chronic inflammation in high fat diet challenged C57BL/6J mice is associated with acceleration of age-dependent renal amyloidosis |
| Q37093643 | Obesity-metabolic derangement preserves hemodynamics but promotes intrarenal adiposity and macrophage infiltration in swine renovascular disease |
| Q38122630 | Obesity-related glomerulopathy and the nephron complement |
| Q38837343 | Occupational exposure to respirable crystalline silica and chronic non-malignant renal disease: systematic review and meta-analysis. |
| Q35928484 | Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006. |
| Q34589532 | Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study |
| Q33551642 | Pediatric Metabolic Syndrome: Pathophysiology and Laboratory Assessment |
| Q81360568 | Pediatric nephrology patients are overweight: 20 years' experience in a single Canadian tertiary pediatric nephrology clinic |
| Q30829502 | Physical activity and metabolic health in chronic kidney disease: a cross-sectional study |
| Q64068145 | Post-weaning Exposure to High-Fat Diet Induces Kidney Lipid Accumulation and Function Impairment in Adult Rats |
| Q47393085 | Potential impact of renin-angiotensin system inhibitors and calcium channel blockers on plasma high-molecular-weight adiponectin levels in hemodialysis patients |
| Q37869829 | Potential nutritional conflicts in bariatric and renal transplant patients. |
| Q84593608 | Prevalence of chronic kidney disease in China |
| Q64081008 | Prevalence of metabolic syndrome in dialysis and transplant patients |
| Q33610654 | Prevention of obesity-induced renal injury in male mice by DPP4 inhibition |
| Q37601862 | Proteinuria in Apparently Healthy Elderly Dogs: Persistency and Comparison Between Free Catch and Cystocentesis Urine |
| Q37360338 | Proteomic and phosphoproteomic analysis of renal cortex in a salt-load rat model of advanced kidney damage |
| Q35005734 | Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria |
| Q34936316 | Recent advances in the pathophysiology of nephrolithiasis |
| Q84435652 | Recovery of renal function in a dialysis-dependent patient following gastric bypass surgery |
| Q34998284 | Reduction of renal triglyceride accumulation: effects on proximal tubule Na+/H+ exchange and urinary acidification |
| Q93609219 | References |
| Q34211573 | Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids |
| Q34362642 | Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic Steatohepatitis |
| Q35896622 | Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort |
| Q49949093 | Renal fat fraction and diffusion tensor imaging in patients with early-stage diabetic nephropathy |
| Q37022748 | Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial |
| Q34825296 | Renal lipid metabolism and lipotoxicity |
| Q30360386 | Renal outcomes of bariatric surgery in obese adults with diabetic kidney disease. |
| Q38842693 | Renoprotective effect of a combination of garlic and telmisartan against ischemia/reperfusion-induced kidney injury in obese rats |
| Q35664491 | Risk factors and their interaction on chronic kidney disease: A multi-centre case control study in Taiwan |
| Q24610857 | Role of nuclear receptor corepressor RIP140 in metabolic syndrome |
| Q24594814 | Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective |
| Q41699701 | Sagittal abdominal diameter as an anthropometric measure of cardiovascular and graft loss risk in renal transplant recipients |
| Q64078970 | Serum klotho is inversely associated with metabolic syndrome in chronic kidney disease: results from the KNOW-CKD study |
| Q44634038 | Sex influences the effect of body mass index on the vascular response to angiotensin II in humans. |
| Q38825855 | Simvastatin attenuates oleic acid-induced oxidative stress through CREB-dependent induction of heme oxygenase-1 in renal proximal tubule cells |
| Q37683444 | Sleep duration and chronic kidney disease: The Korean Genome and Epidemiology Study (KoGES)-Kangwha study |
| Q50588263 | Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance. |
| Q38510757 | The ACACB gene rs2268388 polymorphism is associated with nephropathy in Caucasian patients with diabetes: a meta-analysis |
| Q47136838 | The Renal Pathology of Obesity |
| Q37924425 | The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease |
| Q38254887 | The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis |
| Q42201543 | The effect of obesity and type 1 diabetes on renal function in children and adolescents |
| Q33570124 | The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria |
| Q37148305 | The influence of body composition on renal function in patients with coronary artery disease and its prognostic significance: a retrospective cohort study |
| Q41644342 | The risk of chronic kidney disease in a metabolically healthy obese population |
| Q36250127 | The role of nuclear receptors in the kidney in obesity and metabolic syndrome |
| Q39180146 | Three-year incidence of elevated albuminuria and associated factors in a population-based cohort: The Taichung Community Health Study |
| Q38187597 | Treatment strategies to prevent renal damage in hypertensive children |
| Q37917648 | Uric acid: a starring role in the intricate scenario of metabolic syndrome with cardio-renal damage? |
| Q34639560 | Urinary Cystatin C as a Potential Risk Marker for Cardiovascular Disease and Chronic Kidney Disease in Patients with Obesity and Metabolic Syndrome |
| Q37395121 | Urinary Netrin-1: A New Biomarker for the Early Diagnosis of Renal Damage in Obese Children |
| Q33937580 | Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery |
| Q89883916 | Visceral Adiposity Index and Chronic Kidney Disease in a Non-Diabetic Population: A Cross-Sectional Study |
| Q55019846 | Weight loss has an additive effect on the proteinuria reduction of angiotensin II receptor blockers in hypertensive patients with chronic kidney disease. |
| Q35006811 | Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis |
| Q37465201 | Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway. |
Search more.